However, CD235a+ PS+ RBC-derived EVs demonstrated a possibility to improve predictive value of NT-proBNP and this finding is considered extremely important for patients with low levels of the pro-peptide during treatment of HF. This evidence concerns the gene NPPB and hydrops fetalis.